WADA has said they will appeal the RFEC decision, apparently with or without UCI. An important part of the case Bert is trying to make in his defense is the improbability that he could have tested positive for clenbuterol (CB) as a result of a blood transfusion containing this substance. His arguments will hinge on pharmacokinetics, that is, the rate at which CB is cleared from the body. Here are three studies of CB I found helpful and relevant to this issue (I haven‘t provided links, but given enough information to access the article or abstract quickly; the first one I believe is not at PubMed, but they're all available at Google Scholar):
Yamamoto et al. (1985) - single dose of 20, 40 or 80 ug given to human volunteers. Plasma levels reached maximum of 100, 200 and 350 pg/ml. in 2.5 hours and lasted for 6 hours. When administered orally twice daily, maximum of 200-300 (20 ug dose) and 500-600 (40 ug dose) reached in four days. After 72 hours, 20% of single dose found in urine.
Comment: So when a single oral dose of 20 ug was taken, about 4 ug total was passed in the urine in 72 hours. For a typical individual, about 4 l. of urine are passed in this time period, so the average concentration of CB in urine is about 1 ng/ml., below some detection limits. Of course, this is only an average. It is much higher shortly after dosing. I will get to this in a moment. It would also be higher if the CB is taken regularly. Thus when subjects were given CB twice daily, after four days plasma levels were 2-3 times higher than after a single dose. Presumably, urine levels would be proportionately higher as well.
Meyer and Rinke (1991) - 5 ug/kg. given twice a day for 3 weeks to calves. Urine taken at multiple periods after dosing stopped. Highest concentration was 112 ng/ml., but this is probably outlier. Most concentrations up to 1 day withdrawal fell between 10-40 ng/ml, decreasing after that.
Comment: The dose of 5 ug/kg used in this study is referred to as an anabolic dose, compared to a lower therapeutic dose (for asthma, e.g.). I believe, however, when CB is used by athletes for weight loss or to increase muscle/fat ratio, doses in the therapeutic range (20-100 ug) are used. Someone who has used CB for this purpose, or knows others who have, can maybe correct and/or enlighten me further on this issue.
Anyway, my assumption is that a rider would take about 10% of this dose, e.g., 30 ug for a 60 kg rider would be 0.5 ug/kg. Extrapolating from this study of a different species, urine levels would mostly be in the range of 1-4 ng/ml, IOW, sometimes below the sensitivity of some labs to detect. And after one day, they would generally drop below 1 ng/ml. So unless a rider was being tested on very sensitive equipment, clearing to the point of a negative test could take place within as little as 24 hours, and most often within 2-3 days.
Smith and Paulson (1997) - 3mg/kg single oral dose given to calves. Pooled urine taken at 6 or 12 hour intervals. 36-47% of original CB administered found in urine after 48 hours. Individual pools contained 5-13%.
This study of a single dose found a larger % of CB ending up in the urine than the Yamamoto study. This could be a species difference, humans vs. calves. Extrapolating to a 20 ug. dose in humans, about 8 ug would collect in the urine in 48 hours, and about 1-2.5 ug per 6 or 12 hour pool, as they were described in this study. Assuming a pool contains 500 ml., this corresponds to 2-5 ng/ml.
So from these data, even a single relatively low dose of CB would be fairly detectable in urine up to 48 hours. However, the study noted that most of the original dose had been accounted for by this period, so presumably after 48 hours, a subject would test negative except possibly for the most sensitive equipment.
Conclusions:
1) a rider taking CB at therapeutic but I believe still performance-enhancing levels, say, less than 100 ug per dose, could probably pass all but the most sensitive tests within three days of terminating the doping. So if the program were used for a single week, there would be a ten day period of vulnerability. Moreover, if he took a dose in the low range, say 20-30 ug, it's conceivable that, depending on the sensitivity of the test, he could pass all the tests even during the doping period.
2) I don’t know if CB would be very useful if taken as a single dose, but if a rider did do this, it would very likely go undetected unless he was tested within 48 or even 24 hours of taking the substance. IOW, a very low risk move.
3) If micro dosing is possible and effective--say, taking a dose of less than 10 ug.daily over a period of time--a rider could very conceivably pass all but the most sensitive tests even if they were administered during the period he was doping.
4) These conclusions address the issue of whether testing during June, when speculation suggests any blood withdrawal most likely would have occurred, could have detected the use of CB that then ended up in the blood being transfused. However, even if it can be established that Bert could have gotten away with taking CB during this period, there is an additional question: how much CB would he have to take for it to show up as a 50 pg positive following transfusion?
As I have discussed in the Contador acquitted thread, the amount of blood transfused is typically 5-10% of total blood volume. So had he hypothetically been tested at the time he was withdrawing blood, he would have had, at a minimum, 10-20 times higher urine levels, i.e., 500-1000 pg/ml. This range, while still below the sensitivity of some labs, is actually an underestimate (see the other thread). The actual value would have to be somewhat higher, probably 2 ng/ml or more. As we have seen, this is consistent with using therapeutic doses of CB. So the level Bert actually tested for is, in this respect, quite consistent with resulting from a transfusion.
However, to reach this level originally, before withdrawal, he would most likely have taken CB regularly, at moderate to high therapeutic doses, for at least several days, extending his period of vulnerability to testing. This is where data on when he was tested become very critical to his case, IMO. If he was tested during this period, Bert needs to make the case that the test would not have allowed him to get away with taking doses large enough and often enough to provide the levels obtained after transfusion.
If it turns out he was not tested at all during this period, then I think his case that transfusion would not explain his positive collapses. If he was tested at some point, then the fun begins.
Yamamoto et al. (1985) - single dose of 20, 40 or 80 ug given to human volunteers. Plasma levels reached maximum of 100, 200 and 350 pg/ml. in 2.5 hours and lasted for 6 hours. When administered orally twice daily, maximum of 200-300 (20 ug dose) and 500-600 (40 ug dose) reached in four days. After 72 hours, 20% of single dose found in urine.
Comment: So when a single oral dose of 20 ug was taken, about 4 ug total was passed in the urine in 72 hours. For a typical individual, about 4 l. of urine are passed in this time period, so the average concentration of CB in urine is about 1 ng/ml., below some detection limits. Of course, this is only an average. It is much higher shortly after dosing. I will get to this in a moment. It would also be higher if the CB is taken regularly. Thus when subjects were given CB twice daily, after four days plasma levels were 2-3 times higher than after a single dose. Presumably, urine levels would be proportionately higher as well.
Meyer and Rinke (1991) - 5 ug/kg. given twice a day for 3 weeks to calves. Urine taken at multiple periods after dosing stopped. Highest concentration was 112 ng/ml., but this is probably outlier. Most concentrations up to 1 day withdrawal fell between 10-40 ng/ml, decreasing after that.
Comment: The dose of 5 ug/kg used in this study is referred to as an anabolic dose, compared to a lower therapeutic dose (for asthma, e.g.). I believe, however, when CB is used by athletes for weight loss or to increase muscle/fat ratio, doses in the therapeutic range (20-100 ug) are used. Someone who has used CB for this purpose, or knows others who have, can maybe correct and/or enlighten me further on this issue.
Anyway, my assumption is that a rider would take about 10% of this dose, e.g., 30 ug for a 60 kg rider would be 0.5 ug/kg. Extrapolating from this study of a different species, urine levels would mostly be in the range of 1-4 ng/ml, IOW, sometimes below the sensitivity of some labs to detect. And after one day, they would generally drop below 1 ng/ml. So unless a rider was being tested on very sensitive equipment, clearing to the point of a negative test could take place within as little as 24 hours, and most often within 2-3 days.
Smith and Paulson (1997) - 3mg/kg single oral dose given to calves. Pooled urine taken at 6 or 12 hour intervals. 36-47% of original CB administered found in urine after 48 hours. Individual pools contained 5-13%.
This study of a single dose found a larger % of CB ending up in the urine than the Yamamoto study. This could be a species difference, humans vs. calves. Extrapolating to a 20 ug. dose in humans, about 8 ug would collect in the urine in 48 hours, and about 1-2.5 ug per 6 or 12 hour pool, as they were described in this study. Assuming a pool contains 500 ml., this corresponds to 2-5 ng/ml.
So from these data, even a single relatively low dose of CB would be fairly detectable in urine up to 48 hours. However, the study noted that most of the original dose had been accounted for by this period, so presumably after 48 hours, a subject would test negative except possibly for the most sensitive equipment.
Conclusions:
1) a rider taking CB at therapeutic but I believe still performance-enhancing levels, say, less than 100 ug per dose, could probably pass all but the most sensitive tests within three days of terminating the doping. So if the program were used for a single week, there would be a ten day period of vulnerability. Moreover, if he took a dose in the low range, say 20-30 ug, it's conceivable that, depending on the sensitivity of the test, he could pass all the tests even during the doping period.
2) I don’t know if CB would be very useful if taken as a single dose, but if a rider did do this, it would very likely go undetected unless he was tested within 48 or even 24 hours of taking the substance. IOW, a very low risk move.
3) If micro dosing is possible and effective--say, taking a dose of less than 10 ug.daily over a period of time--a rider could very conceivably pass all but the most sensitive tests even if they were administered during the period he was doping.
4) These conclusions address the issue of whether testing during June, when speculation suggests any blood withdrawal most likely would have occurred, could have detected the use of CB that then ended up in the blood being transfused. However, even if it can be established that Bert could have gotten away with taking CB during this period, there is an additional question: how much CB would he have to take for it to show up as a 50 pg positive following transfusion?
As I have discussed in the Contador acquitted thread, the amount of blood transfused is typically 5-10% of total blood volume. So had he hypothetically been tested at the time he was withdrawing blood, he would have had, at a minimum, 10-20 times higher urine levels, i.e., 500-1000 pg/ml. This range, while still below the sensitivity of some labs, is actually an underestimate (see the other thread). The actual value would have to be somewhat higher, probably 2 ng/ml or more. As we have seen, this is consistent with using therapeutic doses of CB. So the level Bert actually tested for is, in this respect, quite consistent with resulting from a transfusion.
However, to reach this level originally, before withdrawal, he would most likely have taken CB regularly, at moderate to high therapeutic doses, for at least several days, extending his period of vulnerability to testing. This is where data on when he was tested become very critical to his case, IMO. If he was tested during this period, Bert needs to make the case that the test would not have allowed him to get away with taking doses large enough and often enough to provide the levels obtained after transfusion.
If it turns out he was not tested at all during this period, then I think his case that transfusion would not explain his positive collapses. If he was tested at some point, then the fun begins.